File: bbe21bvw8_pub_fr.pdfTrial reference: Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated with Variants in the RPGR geneDoc type: Information for the public